Generate:Biomedicines alternatives and competitors
The closest alternatives to Generate:Biomedicines are Absci, Profluent, Isomorphic Labs and Nabla Bio.
Generate:Biomedicines, a Somerville, Massachusetts company founded by Flagship Pioneering in 2018 and listed on Nasdaq since February 2026, designs protein medicines with machine learning rather than finding them in nature.
10 alternatives to Generate:Biomedicines
What each product does, with its price as the vendor publishes it.
-
A
Absci designs antibodies with generative AI and develops them as its own medicines and with partners.
Price: No published price
-
P
Protein design company in Emeryville, California, built on the ProGen family of protein language models, which grew out of research first showing that large language models can generate functional proteins across diverse families, published in Nature Biotechnology in 2023.
Price: OpenCRISPR-1 free to license, other terms not published
-
I
Isomorphic Labs is a London based AI drug design company founded in 2021 by Sir Demis Hassabis, who leads it as chief executive.
Price: Not applicable
-
N
Nabla Bio designs antibodies on a computer for pharmaceutical partners, then makes and tests them in its own lab.
Price: No published price
-
B
BigHat Biosciences, founded in San Mateo, California in 2019 by Mark DePristo and Peyton Greenside, designs and engineers antibodies with machine learning tied to its own automated laboratory, starting from an existing molecule, its own or a partner's, and improving it in rounds.
Price: No published price
-
I
Insilico Medicine is a generative AI drug discovery company (HKEX: 3696), headquartered in Cambridge, Massachusetts with operations in Hong Kong, Abu Dhabi and Shanghai, that both licenses software and develops its own medicines.
Price: No published price
-
G
Galux designs protein therapeutics with an AI platform that it pairs with the physics of how proteins fold. It is based in Seoul and works through pharmaceutical partnerships.
Price: No published price
-
E
Earendil Labs uses AI to design antibody drugs and develops them through its own pipeline, licensing individual programs to large pharmaceutical companies.
Price: No published price
-
L
Lila Sciences makes very large claims about what its platform can do, and as of September 2026 it has begun publishing evidence for some of them.
Price: No published price
-
B
Biolojic Design uses machine learning to design antibodies that do more than block a target: epitope specific agonists and antagonists, conditional binders, and what it calls multibodies, single symmetrical antibodies that bind more than one target on the same arm.
Price: No published price
Generate:Biomedicines alternatives, answered
What are the best alternatives to Generate:Biomedicines?
The closest alternatives to Generate:Biomedicines are Absci, Profluent, Isomorphic Labs, Nabla Bio and BigHat Biosciences. Absci designs antibodies with generative AI and develops them as its own medicines and with partners. Isomorphic Labs is a London based AI drug design company founded in 2021 by Sir Demis Hassabis, who leads it as chief executive. Nabla Bio designs antibodies on a computer for pharmaceutical partners, then makes and tests them in its own lab.
Who are Generate:Biomedicines's competitors?
Generate:Biomedicines's competitors in the Drug Discovery AI category include Absci, Profluent, Isomorphic Labs, Nabla Bio, BigHat Biosciences and Insilico Medicine.